TrialJournal of microbiology and biotechnology2025
Safety and Tolerability of HemoHIM: A Randomized, Placebo-Controlled, Double-Blind, and Parallel Clinical Trial in Healthy Human Volunteers.
Ji-Won Seo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.